Benzenepropanamide, a-(methylamino)-N-[7-(1-methylpropyl)-5,8-dioxo-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14,15-tetraen-4-yl]-(9CI) (29432-61-9)

Identification
Name:	Benzenepropanamide, a-(methylamino)-N-[7-(1-methylpropyl)-5,8-dioxo-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14,15-tetraen-4-yl]-(9CI)
Synonyms:	AralionineB (8CI); 2-Oxa-6,9-diazabicyclo[10.2.2]hexadecane, benzenepropanamide deriv.
CAS:	29432-61-9
Molecular Formula:	C33H38 N4 O4
Molecular Structure:
Properties
Safety Data

Other Product

Benzenepropanamide, a-(methylamino)-N-[3-(1-methylethyl)-7-(2-methylpropyl)-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14,15-tetraen-4-yl]-(9CI)
Benzenepropanamide, a-(dimethylamino)-N-[7-(1-hydroxy-2-methylpropyl)-3-(1-methylethyl)-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14,15-tetraen-4-yl]-(9CI)
Benzenepropanamide, a-(dimethylamino)-N-[3-(1-methylethyl)-7-(1-methylpropyl)-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14,15-tetraen-4-yl]-(9CI)
Benzenepropanamide, a-(dimethylamino)-N-[(3R,4S,7S)-7-(2-methylpropyl)-5,8-dioxo-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14,15-tetraen-4-yl]-,(aS)-
Benzenepropanamide,R-(dimethylamino)-N- [(3R,4S,7S)-3-(1-methylethyl)-7-[(1R)-1- methylpropyl]-5,8-dioxo-2-oxa-6,9- diazabicyclo[10.2.2]hexadeca-10,12,14,15- tetraen-4-yl]-,(RS)-
Benzenepropanamide, a-(dimethylamino)-N-[(3R,4S,7S)-3-(1-methylethyl)-7-(2-methylpropyl)-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14,15-tetraen-4-yl]-,(aR)-
2-Propenamide,N-[3-(1-methylethyl)-7-(2-methylpropyl)-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14,15-tetraen-4-yl]-3-phenyl-(9CI)
Pentanamide,2-(dimethylamino)-4-methyl-N-[7-(1-methylpropyl)-5,8-dioxo-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14,15-tetraen-4-yl]-(9CI)
Butanamide,2-(dimethylamino)-3-hydroxy-N- [7-(2-methylpropyl)-5,8-dioxo-3-phenyl-2- oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14,- 15-tetraen-4-yl]-
Nalpha,Nalpha-dimethyl-N-[(10Z)-3-(1-methylethyl)-7-(1-methylpropyl)-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),10,12,15-tetraen-4-yl]tryptophanamide
Pentanamide,2-(dimethylamino)-3-methyl-N- [7-(1-methylethyl)-5,8-dioxo-3-phenyl-2- oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14,- 15-tetraen-4-yl]-
Pentanamide,N-[7-(1H-indol-3-ylmethyl)-3-(1-methylethyl)-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14,15-tetraen-4-yl]-4-methyl-2-(methylamino)-(9CI)
Pentanamide,N-[7-(1H-indol-3-ylmethyl)-3-(1-methylethyl)-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14,15-tetraen-4-yl]-3-methyl-2-(methylamino)-(9CI)
1H-Indole-3-propanamide,a-(dimethylamino)-N-[3-(1-methylethyl)-7-(2-methylpropyl)-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-10,12,14,15-tetraen-4-yl]-(9CI)
Benzenepropanamide, a-(dimethylamino)-N-[11-methoxy-3-(1-methylethyl)-7-(2-methylpropyl)-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-12,14,15-trien-4-yl]-(9CI)
Benzenepropanamide,R-(dimethylamino)-N- [(3R,4S,7R)-7-[(S)-hydroxyphenylmethyl]-3- (1-methylethyl)-5,8-dioxo-2-oxa-6,9- diazabicyclo[10.2.2]hexadeca-10,12,14,15- tetraen-4-yl]-,(RS)-
Benzenepropanamide,R-(dimethylamino)-N- [(3S,4S,7R,10Z)-7-[(S)-hydroxyphenylmethyl]- 3-(1-methylethyl)-5,8-dioxo-2-oxa-6,9- diazabicyclo[10.2.2]hexadeca-10,12,14,15- tetraen-4-yl]-,(RS)-
Nalpha,Nalpha-dimethyl-N-[(3R,4S,7S,10Z)-7-[(1S)-1-methylpropyl]-5,8-dioxo-3-phenyl-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),10,12,15-tetraen-4-yl]-L-phenylalaninamide
N-[(3S,4S,7S,10Z)-7-benzyl-3-(1-methylethyl)-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),10,12,15-tetraen-4-yl]-1-methyl-L-prolinamide
(2E)-N-[(3S,7S,10Z)-7-isobutyl-3-isopropyl-5,8-dioxo-2-oxa-6,9-diazabicyclo[10.2.2]hexadeca-1(14),10,12,15-tetraen-4-yl]-4-methylpent-2-enamide